PA Medical News about Zavesca

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat
Therapeutics and Clinical Risk Management, 11/04/09

Wraith JE et al. – Findings demonstrated clinically relevant beneficial effects of miglustat on neurological disease progression in adult, juvenile and pediatric patients with NP–C, particularly those diagnosed in late childhood and in juveniles and adults, compared with those diagnosed in early childhood. With the approval of miglustat, treatment of patients with NP–C can now be aimed toward stabilizing neurological disease, which is likely the best attainable therapeutic goal for this disorder.